Insider sales can sometimes raise eyebrows, but this one’s pretty small—hardly a red flag on its own. Still, shareholders might wonder if McGinnis sees something on the horizon, or if it’s just routine portfolio management. Either way, it’s a reminder that tracking insider moves can offer clues about how leadership really feels.

Patrick McGinnis, a director at biotech company Ibex, just sold $6,600 worth of company shares. While that’s not a massive transaction compared to some insider trades, it’s still worth noting—especially for investors keeping an eye on executive confidence in the business.

Ibex director Patrick McGinnis sells $6,600 in shares

Was this article worth reading? Share it

Ready to build your own newsroom?